Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Neurobiology
  • Track 1-2General neurology
  • Track 1-3Vascular neurology
  • Track 1-4Pain management and Palliative care
  • Track 1-5Neurodevelopment
  • Track 1-6Current neurosurgery method
  • Track 1-7Behavioural neurology
  • Track 1-8Veterinary neurology
  • Track 2-1Neuropsychiatric disturbances
  • Track 2-2Electromyography
  • Track 2-3Electroencephalography
  • Track 2-4Investigating biomarkers
  • Track 2-5Clinical trials
  • Track 2-6Neurogenesis
  • Track 3-1Neurogenetic
  • Track 3-2Brain malformations
  • Track 3-3Paediatric sleep disorders
  • Track 3-4Developmental disorders including autism
  • Track 3-5Paediatric neuromuscular disorders
  • Track 3-6Concussion
  • Track 3-7Hypertonic and Hypotonic Cerebral Palsy
  • Track 4-1Simple partial seizure
  • Track 4-2Complex partial seizure
  • Track 4-3Aura
  • Track 4-4Grand mal seizure
  • Track 4-5Epilepsy syndrome
  • Track 4-6Atonic seizure
  • Track 4-7Partial seizure
  • Track 4-8Generalized seizure
  • Track 5-1Regulatory T cells
  • Track 5-2Idiotype-antiidiotype networks
  • Track 5-3Immune response genes
  • Track 5-4Degenerative disorders
  • Track 5-5Bi-directional effect of immune cell
  • Track 6-1Inflammatory Muscle Disorder
  • Track 6-2Amyotrophic lateral sclerosis
  • Track 6-3Congenital myasthenic syndrome
  • Track 6-4Hereditary spastic paraplegia
  • Track 6-5Lambert–Eaton myasthenic syndrome
  • Track 6-6Spinal and bulbar muscular atrophy
  • Track 6-7Troyer syndrome
  • Track 6-8Guillain–Barré syndrome
  • Track 7-1Astrocytoma(s)
  • Track 7-2Arteriovenous malformation
  • Track 7-3CNS lymphoma(s)
  • Track 7-4Brain tumor
  • Track 7-5 Brain stem tumors
  • Track 7-6Ependymoma
  • Track 8-1Cerebral palsy
  • Track 8-2Behavioural Neurology
  • Track 8-3Craniofacial abnormalities
  • Track 8-4Craniosynostosis
  • Track 8-5Developmental disorders
  • Track 8-6Encephalopathy
  • Track 9-1Mammography
  • Track 9-2Magnetic resonance imaging
  • Track 9-3Magnetoencephalography
  • Track 9-4Positron emission tomography
  • Track 9-5Computed axial tomography
  • Track 10-1General neurosurgery
  • Track 10-2Functional and epilepsy neurosurgery.
  • Track 10-3Astrocytoma
  • Track 10-4Stroke
  • Track 10-5Epilepsy
  • Track 10-6CNS lymphoma
  • Track 11-1Arachnoid cysts
  • Track 11-2Attention deficit/hyperactivity disorder (ADHD)
  • Track 11-3Autism
  • Track 11-4Depression
  • Track 11-5Encephalitis
  • Track 11-6Locked-in syndrome
  • Track 11-7Meningitis
  • Track 11-8Myelopathy
  • Track 12-1Cerebrovascular diseases
  • Track 12-2Therapeutic targets & mechanisms for treatment
  • Track 12-3Alzheimer’s disease symptoms
  • Track 12-4Brain injuring unit
  • Track 12-5Rehabilitation facilities
  • Track 13-1GABA
  • Track 13-2Dopamine
  • Track 13-3Serotonin
  • Track 13-4Ion channels
  • Track 13-5Ethanol
  • Track 14-1Vascular dementia
  • Track 14-2Dementia with Lewy bodies (DLB)
  • Track 14-3Alzheimer’s disorder
  • Track 14-4Mixed dementia
  • Track 14-5Frontotemporal dementia
  • Track 14-6Creutzfeldt-Jakob disease
  • Track 14-7Epilepsy syndrome
  • Track 14-8Wernicke-Korsakoff Syndrome
  • Track 15-1Stroke
  • Track 15-2Cerebral palsy
  • Track 15-3Cognitive Deficit
  • Track 15-4Acute Stroke
  • Track 15-5Cerebrovascular Disorders
  • Track 16-1Ischemic stroke
  • Track 16-2Transient Ischemic attack
  • Track 16-3Hemorrhagic stroke
  • Track 16-4Acute Brain Injury
  • Track 16-5GENDCSS(NIH)
  • Track 16-6Brain and Cardiac monitoring